Does LARONIDASE Cause Infusion site extravasation? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Infusion site extravasation have been filed in association with LARONIDASE (ALDURAZYME). This represents 0.7% of all adverse event reports for LARONIDASE.
21
Reports of Infusion site extravasation with LARONIDASE
0.7%
of all LARONIDASE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Infusion site extravasation From LARONIDASE?
Of the 21 reports, 5 (23.8%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LARONIDASE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does LARONIDASE Cause?
Pyrexia (423)
Malaise (169)
Pneumonia (162)
Dyspnoea (157)
Vomiting (157)
Cough (154)
Fatigue (137)
Influenza (108)
Pain (107)
Inappropriate schedule of product administration (106)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which LARONIDASE Alternatives Have Lower Infusion site extravasation Risk?
LARONIDASE vs LAROTRECTINIB
LARONIDASE vs LASILIX
LARONIDASE vs LASIX
LARONIDASE vs LASMIDITAN
LARONIDASE vs LATANOPROST